Improving quality of care in patients with Barrett’s esophagus by measuring and improving neoplasia detection rates

The goal of screening and surveillance endoscopy in patients with Barrett's esophagus (BE) is to reduce the rising incidence of esophageal adenocarcinoma (EAC) and ultimately mortality from this lethal cancer.1 However, despite all advances in the field of screening, surveillance, and treatment of BE, we have not made a significant dent in the incidence of this cancer. One potential explanation is the quality gap in the care of patients with BE and dysplasia. Unlike for the management of colonoscopy and colorectal cancer, there are no uniformly agreed-upon quality metrics for the care of BE patients.

https://ift.tt/2EFnOl9